Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision number was updated from v3.6.3 to v3.6.4, indicating a minor update to the document.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata or backend; the visible study details and layout remain unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. This indicates a platform update and does not alter the study information presented on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedEnrollment status was updated to indicate no further participant recruitment. The page additionally adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment heading, including a Revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check61 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a small patch to the page without altering the visible study details.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new version of the page. It reflects minor maintenance or enhancements to the page's content or underlying code.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.